Mcia Inc Nektar Therapeutics Transaction History

Mcia Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 13, 2021	BUY	$15.77 - $19.03 $157,700 - $190,300	10,000 New	10,000 $187,000
Q4 2020 Jan 12, 2021	SELL	$15.77 - $19.03 $173,470 - $209,330	-11,000 Closed	0 $0
Q2 2020 Jul 08, 2020	BUY	$16.86 - $23.44 $16,860 - $23,440	1,000 Added 10.0%	11,000 $266,000
Q3 2019 Oct 25, 2019	BUY	$16.91 - $36.27 $169,100 - $362,700	10,000 New	10,000 $182,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Mcia Inc, based on Form 13F filings with the SEC.

Stay updated on Mcia Inc with notifications on news.